Shares of R1 RCM Inc (NASDAQ:RCM) have earned an average recommendation of “Buy” from the seven analysts that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $15.00.
A number of research analysts recently commented on the company. Cantor Fitzgerald boosted their price target on R1 RCM from $11.00 to $13.00 and gave the company an “overweight” rating in a research note on Friday, April 12th. Zacks Investment Research downgraded R1 RCM from a “buy” rating to a “hold” rating in a research note on Saturday, April 27th. BidaskClub raised R1 RCM from a “hold” rating to a “buy” rating in a research note on Thursday, April 25th. Finally, KeyCorp assumed coverage on R1 RCM in a research note on Tuesday, January 22nd. They issued an “overweight” rating and a $10.00 price target for the company.
A number of institutional investors have recently added to or reduced their stakes in RCM. SCW Capital Management LP bought a new stake in shares of R1 RCM during the fourth quarter worth about $29,745,000. Millennium Management LLC raised its position in shares of R1 RCM by 143.6% during the fourth quarter. Millennium Management LLC now owns 1,968,470 shares of the financial services provider’s stock worth $15,649,000 after purchasing an additional 1,160,264 shares during the period. BlackRock Inc. raised its position in shares of R1 RCM by 10.9% during the third quarter. BlackRock Inc. now owns 7,603,992 shares of the financial services provider’s stock worth $77,255,000 after purchasing an additional 746,909 shares during the period. Eversept Partners LP raised its position in shares of R1 RCM by 39.4% during the fourth quarter. Eversept Partners LP now owns 2,349,306 shares of the financial services provider’s stock worth $18,677,000 after purchasing an additional 664,219 shares during the period. Finally, Royce & Associates LP bought a new stake in R1 RCM during the fourth quarter worth $4,492,000. Hedge funds and other institutional investors own 65.69% of the company’s stock.
R1 RCM (NASDAQ:RCM) last posted its quarterly earnings results on Thursday, May 9th. The financial services provider reported ($0.04) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.05) by $0.01. The business had revenue of $275.90 million during the quarter, compared to the consensus estimate of $266.37 million. R1 RCM had a negative return on equity of 145.94% and a negative net margin of 5.22%. R1 RCM’s revenue for the quarter was up 87.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.26) earnings per share. On average, sell-side analysts predict that R1 RCM will post 0.25 earnings per share for the current fiscal year.
R1 RCM Company Profile
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Read More: The basics of gap trading strategies
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.